Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health

Mariya I Petrova, Elke Lievens, Shweta Malik, Nicole Imholz, Sarah Lebeer, Mariya I Petrova, Elke Lievens, Shweta Malik, Nicole Imholz, Sarah Lebeer

Abstract

The human body is colonized by a vast number of microorganisms collectively referred to as the human microbiota. One of the main microbiota body sites is the female genital tract, commonly dominated by Lactobacillus spp., in approximately 70% of women. Each individual species can constitute approximately 99% of the ribotypes observed in any individual woman. The most frequently isolated species are Lactobacillus crispatus, Lactobacillus gasseri, Lactobacillus jensenii and Lactobacillus iners. Residing at the port of entry of bacterial and viral pathogens, the vaginal Lactobacillus species can create a barrier against pathogen invasion since mainly products of their metabolism secreted in the cervicovaginal fluid can play an important role in the inhibition of bacterial and viral infections. Therefore, a Lactobacillus-dominated microbiota appears to be a good biomarker for a healthy vaginal ecosystem. This balance can be rapidly altered during processes such as menstruation, sexual activity, pregnancy and various infections. An abnormal vaginal microbiota is characterized by an increased diversity of microbial species, leading to a condition known as bacterial vaginosis. Information on the vaginal microbiota can be gathered from the analysis of cervicovaginal fluid, by using the Nugent scoring or the Amsel's criteria, or at the molecular level by investigating the number and type of Lactobacillus species. However, when translating this to the clinical setting, it should be noted that the absence of a Lactobacillus-dominated microbiota does not appear to directly imply a diseased condition or dysbiosis. Nevertheless, the widely documented beneficial role of vaginal Lactobacillus species demonstrates the potential of data on the composition and activity of lactobacilli as biomarkers for vaginal health. The substantiation and further validation of such biomarkers will allow the design of better targeted probiotic strategies.

Keywords: STIs; bacterial vaginosis; lactobacilli; probiotics; vaginal microbiota.

Figures

Figure 1
Figure 1
Composition of VMB during healthy and dysbiotic states. The vaginal microbiota in healthy adult premenopausal women can be divided into different community groups. The exact number and type of community groups is still under debate (Verhelst et al., ; Ravel et al., ; Gajer et al., ; Santiago et al., 2012). The most commonly isolated dominating species belong to L. crispatus, L. gasseri, L. iners and L. jensenii. The vaginal community group dominated by L. iners is also often isolated during menstruation and in the transitional microbiota between healthy and BV state or vice-versa. Because this species is often isolated during BV, L. iners may not be able to effectively protect against pathogens. Additionally, a non-Lactobacillus dominated VMB is also documented in various healthy individuals (Zhou et al., ; Ravel et al., ; Santiago et al., 2012). For each compositional state, we have added an example of their abundance based on the study of Ravel et al. (2011). However, these numbers are only exemplary and should be considered with caution, as they clearly depend on the study population (size and characteristics) and they certainly need to be substantiated in further studies.

References

    1. Allsworth J. E., Lewis V. A., Peipert J. F. (2008). Viral sexually transmitted infections and bacterial vaginosis: 2001-2004 national health and nutrition examination survey data. Sex. Transm. Dis. 35, 791–796. 10.1097/OLQ.0b013e3181788301
    1. Amsel R., Totten P. A., Spiegel C. A., Chen K. C., Eschenbach D., Holmes K. K. (1983). Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am. J. Med. 74, 14–22.
    1. Andersch B., Forssman L., Lincoln K., Torstensson P. (1986). Treatment of bacterial vaginosis with an acid cream: a comparison between the effect of lactate-gel and metronidazole. Gynecol. Obstet. Invest. 21, 19–25. 10.1159/000298923
    1. Antonio M. A., Hawes S. E., Hillier S. L. (1999). The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. J. Infect. Dis. 180, 1950–1956.
    1. Anukam K. C., Macklaim J. M., Gloor G. B., Reid G., Boekhorst J., Renckens B., et al. . (2013). Genome sequence of Lactobacillus pentosus KCA1: vaginal isolate from a healthy premenopausal woman. PLoS ONE 8:e59239. 10.1371/journal.pone.0059239
    1. Anukam K. C., Osazuwa E. O., Ahonkhai I., Reid G. (2006c). Lactobacillus vaginal microbiota of women attending a reproductive health care service in Benin city, Nigeria. Sex Transm. Dis. 33, 59–62. 10.1097/01.olq.0000175367.15559.c4
    1. Anukam K. C., Osazuwa E. O., Osadolor H. B., Bruce A. W., Reid G. (2008). Yogurt containing probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 helps resolve moderate diarrhea and increases CD4 count in HIV/AIDS patients. J. Clin. Gastroenterol. 42, 239–243. 10.1097/MCG.0b013e31802c7465
    1. Anukam K. C., Osazuwa E., Osemene G. I., Ehigiagbe F., Bruce A. W., Reid G. (2006b). Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes. Infect. 8, 2772–2776. 10.1016/j.micinf.2006.08.008
    1. Anukam K., Osazuwa E., Ahonkhai I., Ngwu M., Osemene G., Bruce A. W., et al. . (2006a). Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microbes. Infect. 8, 1450–1454. 10.1016/j.micinf.2006.01.003
    1. Atashili J., Poole C., Ndumbe P. M., Adimora A. A., Smith J. S. (2008). Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS 22, 1493–1501. 10.1097/QAD.0b013e3283021a37
    1. Atassi F., Brassart D., Grob P., Graf F., Servin A. L. (2006). Lactobacillus strains isolated from the vaginal microbiota of healthy women inhibit Prevotella bivia and Gardnerella vaginalis in coculture and cell culture. FEMS Immunol. Med. Microbiol. 48, 424–432. 10.1111/j.1574-695X.2006.00162.x
    1. Bisanz J. E., Seney S., McMillan A., Vongsa R., Koenig D., Wong L., et al. . (2014). A systems biology approach investigating the effect of probiotics on the vaginal microbiome and host responses in a double blind, placebo-controlled clinical trial of post-menopausal women. PLoS ONE 9:e104511. 10.1371/journal.pone.0104511
    1. Boeke A. J., Dekker J. H., van Eijk J. T., Kostense P. J., Bezemer P. D. (1993). Effect of lactic acid suppositories compared with oral metronidazole and placebo in bacterial vaginosis: a randomised clinical trial. Genitourin. Med. 69, 388–392.
    1. Borgdorff H., Tsivtsivadze E., Verhelst R., Marzorati M., Jurriaans S., Ndayisaba G. F., et al. . (2014). Lactobacillus-dominated cervicovaginal microbiota associated with reduced HIV/STI prevalence and genital HIV viral load in African women. ISME J. 8, 1781–1793. 10.1038/ismej.2014.26
    1. Bradshaw C. S., Pirotta M., De G. D., Hocking J. S., Morton A. N., Garland S. M., et al. . (2012). Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial. PLoS ONE 7:e34540. 10.1371/journal.pone.0034540
    1. Brotman R. M. (2011). Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective. J. Clin. Invest. 121, 4610–4617. 10.1172/JCI57172
    1. Brotman R. M., He X., Gajer P., Fadrosh D., Sharma E., Mongodin E. F., et al. . (2014a). Association between cigarette smoking and the vaginal microbiota: a pilot study. BMC Infect. Dis. 14:471. 10.1186/1471-2334-14-471
    1. Brotman R. M., Klebanoff M. A., Nansel T. R., Andrews W. W., Schwebke J. R., Zhang J., et al. . (2008). A longitudinal study of vaginal douching and bacterial vaginosis–a marginal structural modeling analysis. Am. J. Epidemiol. 168, 188–196. 10.1093/aje/kwn103
    1. Brotman R. M., Klebanoff M. A., Nansel T. R., Yu K. F., Andrews W. W., Zhang J., et al. (2010). Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection. J. Infect. Dis. 202, 1907–1915 10.1086/657320
    1. Brotman R. M., Shardell M. D., Gajer P., Tracy J. K., Zenilman J. M., Ravel J., et al. . (2014b). Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection. J. Infect. Dis. 210, 1723–1733. 10.1093/infdis/jiu330
    1. Burton J. P., Reid G. (2002). Evaluation of the bacterial vaginal flora of 20 postmenopausal women by direct (Nugent score) and molecular (polymerase chain reaction and denaturing gradient gel electrophoresis) techniques. J. Infect. Dis. 186, 1770–1780. 10.1086/345761
    1. Cardone A., Zarcone R., Borrelli A., Di C. A., Russo A., Tartaglia E. (2003). Utilisation of hydrogen peroxide in the treatment of recurrent bacterial vaginosis. Minerva Ginecol. 55, 483–492.
    1. Carey J. C., Klebanoff M. A. (2005). Is a change in the vaginal flora associated with an increased risk of preterm birth? Am. J. Obstet. Gynecol. 192, 1341–1346. 10.1016/j.ajog.2004.12.069
    1. Chaban B., Links M. G., Jayaprakash T. P., Wagner E. C., Bourque D. K., Lohn Z., et al. . (2014). Characterization of the vaginal microbiota of healthy Canadian women through the menstrual cycle. Microbiome 2:23. 10.1186/2049-2618-2-23
    1. Chaithongwongwatthana S., Limpongsanurak S., Sitthi-Amorn C. (2003). Single hydrogen peroxide vaginal douching versus single-dose oral metronidazole for the treatment of bacterial vaginosis: a randomized controlled trial. J. Med. Assoc. Thai. 86(Suppl. 2), S379–S384.
    1. Cherpes T. L., Hillier S. L., Meyn L. A., Busch J. L., Krohn M. A. (2008). A delicate balance: risk factors for acquisition of bacterial vaginosis include sexual activity, absence of hydrogen peroxide-producing lactobacilli, black race, and positive herpes simplex virus type 2 serology. Sex Transm. Dis. 35, 78–83. 10.1097/OLQ.0b013e318156a5d0
    1. Cherpes T. L., Melan M. A., Kant J. A., Cosentino L. A., Meyn L. A., Hillier S. L. (2005). Genital tract shedding of herpes simplex virus type 2 in women: effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization. Clin. Infect. Dis. 40, 1422–1428. 10.1086/429622
    1. Cherpes T. L., Meyn L. A., Krohn M. A., Hillier S. L. (2003a). Risk factors for infection with herpes simplex virus type 2: role of smoking, douching, uncircumcised males, and vaginal flora. Sex Transm. Dis. 30, 405–410. 10.1097/00007435-200305000-00006
    1. Cherpes T. L., Meyn L. A., Krohn M. A., Lurie J. G., Hillier S. L. (2003b). Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin. Infect. Dis. 37, 319–325. 10.1086/375819
    1. Clarke M. A., Rodriguez A. C., Gage J. C., Herrero R., Hildesheim A., Wacholder S., et al. . (2012). A large, population-based study of age-related associations between vaginal pH and human papillomavirus infection. BMC Infect. Dis. 12:33. 10.1186/1471-2334-12-33
    1. Cohen C. R., Lingappa J. R., Baeten J. M., Ngayo M. O., Spiegel C. A., Hong T., et al. . (2012). Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. PLoS Med. 9:e1001251. 10.1371/journal.pmed.1001251
    1. Coleman J. S., Hitti J., Bukusi E. A., Mwachari C., Muliro A., Nguti R., et al. . (2007). Infectious correlates of HIV-1 shedding in the female upper and lower genital tracts. AIDS 21, 755–759. 10.1097/QAD.0b013e328012b838
    1. Conti C., Malacrino C., Mastromarino P. (2009). Inhibition of herpes simplex virus type 2 by vaginal lactobacilli. J. Physiol. Pharmacol. 60(Suppl. 6), 19–26.
    1. Cotter P. D., Ross R. P., Hill C. (2013). Bacteriocins - a viable alternative to antibiotics? Nat. Rev. Microbiol. 11, 95–105. 10.1038/nrmicro2937
    1. Damelin L. H., Paximadis M., Mavri-Damelin D., Birkhead M., Lewis D. A., Tiemessen C. T. (2011). Identification of predominant culturable vaginal Lactobacillus species and associated bacteriophages from women with and without vaginal discharge syndrome in South Africa. J. Med. Microbiol. 60, 180–183. 10.1099/jmm.0.024463-0
    1. Datcu R., Gesink D., Mulvad G., Montgomery-Andersen R., Rink E., Koch A., et al. . (2013). Vaginal microbiome in women from Greenland assessed by microscopy and quantitative PCR. BMC Infect. Dis. 13:480. 10.1186/1471-2334-13-480
    1. De S. F., Parazzini F., De L. R., Banco R., Maso G. P., De S. D., et al. . (2014). Lactobacillus plantarum P17630 for preventing Candida vaginitis recurrence: a retrospective comparative study. Eur. J. Obstet. Gynecol. Reprod. Biol. 182, 136–139. 10.1016/j.ejogrb.2014.09.018
    1. Doerflinger S. Y., Throop A. L., Herbst-Kralovetz M. M. (2014). Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner. J. Infect. Dis. 209, 1989–1999. 10.1093/infdis/jiu004
    1. Dols J. A., Reid G., Kort R., Schuren F. H., Tempelman H., Bontekoe T. R., et al. . (2012). PCR-based identification of eight Lactobacillus species and 18 hr-HPV genotypes in fixed cervical samples of South African women at risk of HIV and BV. Diagn. Cytopathol. 40, 472–477. 10.1002/dc.21786
    1. Dominguez-Bello M. G., Costello E. K., Contreras M., Magris M., Hidalgo G., Fierer N., et al. . (2010). Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl. Acad. Sci. U.S.A. 107, 11971–11975. 10.1073/pnas.1002601107
    1. Donders G. G., Van C. K., Bellen G., Reybrouck R., Van den B. T., Riphagen I., et al. . (2009). Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy. BJOG 116, 1315–1324. 10.1111/j.1471-0528.2009.02237.x
    1. Donia M. S., Cimermancic P., Schulze C. J., Wieland Brown L. C., Martin J., Mitreva M., et al. . (2014). A systematic analysis of biosynthetic gene clusters in the human microbiome reveals a common family of antibiotics. Cell 158, 1402–1414. 10.1016/j.cell.2014.08.032
    1. Drell T., Lillsaar T., Tummeleht L., Simm J., Aaspollu A., Vain E., et al. . (2013). Characterization of the vaginal micro- and mycobiome in asymptomatic reproductive-age Estonian women. PLoS ONE 8:e54379. 10.1371/journal.pone.0054379
    1. Eckert L. O., Moore D. E., Patton D. L., Agnew K. J., Eschenbach D. A. (2003). Relationship of vaginal bacteria and inflammation with conception and early pregnancy loss following in-vitro fertilization. Infect. Dis Obstet. Gynecol. 11, 11–17. 10.1155/S1064744903000024
    1. Ehrstrom S., Daroczy K., Rylander E., Samuelsson C., Johannesson U., Anzen B., et al. . (2010). Lactic acid bacteria colonization and clinical outcome after probiotic supplementation in conventionally treated bacterial vaginosis and vulvovaginal candidiasis. Microbes. Infect. 12, 691–699. 10.1016/j.micinf.2010.04.010
    1. El Aila N. A., Tency I., Claeys G., Verstraelen H., Saerens B., Santiago G. L., et al. . (2009). Identification and genotyping of bacteria from paired vaginal and rectal samples from pregnant women indicates similarity between vaginal and rectal microflora. BMC Infect. Dis. 9:167. 10.1186/1471-2334-9-167
    1. Eriksson K., Carlsson B., Forsum U., Larsson P. G. (2005). A double-blind treatment study of bacterial vaginosis with normal vaginal lactobacilli after an open treatment with vaginal clindamycin ovules. Acta. Derm. Venereol. 85, 42–46. 10.1080/00015550410022249
    1. Falsen E., Pascual C., Sjoden B., Ohlen M., Collins M. D. (1999). Phenotypic and phylogenetic characterization of a novel Lactobacillus species from human sources: description of Lactobacillus iners sp. nov. Int. J. Syst. Bacteriol. 49(Pt 1), 217–221. 10.1099/00207713-49-1-217
    1. Ferris M. J., Norori J., Zozaya-Hinchliffe M., Martin D. H. (2007). Cultivation-independent analysis of changes in bacterial vaginosis flora following metronidazole treatment. J. Clin. Microbiol. 45, 1016–1018. 10.1128/JCM.02085-06
    1. Forney L. J., Gajer P., Williams C. J., Schneider G. M., Koenig S. S., McCulle S. L., et al. . (2010). Comparison of self-collected and physician-collected vaginal swabs for microbiome analysis. J. Clin. Microbiol. 48, 1741–1748. 10.1128/JCM.01710-09
    1. Fredricks D. N., Fiedler T. L., Marrazzo J. M. (2005). Molecular identification of bacteria associated with bacterial vaginosis. N. Engl. J. Med. 353, 1899–1911. 10.1056/NEJMoa043802
    1. Gajer P., Brotman R. M., Bai G., Sakamoto J., Schutte U. M., Zhong X., et al. . (2012). Temporal dynamics of the human vaginal microbiota. Sci. Transl. Med. 4, 132ra52. 10.1126/scitranslmed.3003605
    1. Gallo M. F., Warner L., Macaluso M., Stone K. M., Brill I., Fleenor M. E., et al. . (2008). Risk factors for incident herpes simplex type 2 virus infection among women attending a sexually transmitted disease clinic. Sex Transm. Dis. 35, 679–685. 10.1097/OLQ.0b013e31816fcaf8
    1. Gao W., Weng J., Gao Y., Chen X. (2013). Comparison of the vaginal microbiota diversity of women with and without human papillomavirus infection: a cross-sectional study. BMC Infect. Dis. 13:271. 10.1186/1471-2334-13-271
    1. Gardiner G. E., Heinemann C., Bruce A. W., Beuerman D., Reid G. (2002). Persistence of Lactobacillus fermentum RC-14 and Lactobacillus rhamnosus GR-1 but not L. rhamnosus GG in the human vagina as demonstrated by randomly amplified polymorphic DNA. Clin. Diagn. Lab. Immunol. 9, 92–96 10.1128/CDLI.9.1.92-96.2002
    1. Ghartey J. P., Smith B. C., Chen Z., Buckley N., Lo Y., Ratner A. J., et al. . (2014). Lactobacillus crispatus dominant vaginal microbiome is associated with inhibitory activity of female genital tract secretions against Escherichia coli. PLoS ONE 9:e96659. 10.1371/journal.pone.0096659
    1. Gillet E., Meys J. F., Verstraelen H., Bosire C., De S. P., Temmerman M., et al. . (2011). Bacterial vaginosis is associated with uterine cervical human papillomavirus infection: a meta-analysis. BMC Infect. Dis. 11:10. 10.1186/1471-2334-11-10
    1. Gong Z., Luna Y., Yu P., Fan H. (2014). Lactobacilli inactivate Chlamydia trachomatis through lactic acid but not H2O2. PLoS ONE 9:e107758. 10.1371/journal.pone.0107758
    1. Gottlieb S. L., Douglas J. M., Jr., Foster M., Schmid D. S., Newman D. R., Baron A. E., et al. . (2004). Incidence of herpes simplex virus type 2 infection in 5 sexually transmitted disease (STD) clinics and the effect of HIV/STD risk-reduction counseling. J. Infect. Dis. 190, 1059–1067. 10.1086/423323
    1. Graver M. A., Wade J. J. (2011). The role of acidification in the inhibition of Neisseria gonorrhoeae by vaginal lactobacilli during anaerobic growth. Ann. Clin. Microbiol. Antimicrob. 10:8. 10.1186/1476-0711-10-8
    1. Guise J. M., Mahon S., Aickin M., Helfand M., Peipert J., Westhoff C. (2001). Screening for bacterial vaginosis in pregnancy. Am. J. Prev. Med. 20, 62–67.
    1. Guo Y. L., You K., Qiao J., Zhao Y. M., Geng L. (2012). Bacterial vaginosis is conducive to the persistence of HPV infection. Int. J. STD AIDS 23, 581–584. 10.1258/ijsa.2012.011342
    1. Gustafsson R. J., Ahrne S., Jeppsson B., Benoni C., Olsson C., Stjernquist M., et al. . (2011). The Lactobacillus flora in vagina and rectum of fertile and postmenopausal healthy Swedish women. BMC Womens Health 11, 17–11. 10.1186/1472-6874-11-17
    1. Hallen A., Jarstrand C., Pahlson C. (1992). Treatment of bacterial vaginosis with lactobacilli. Sex Transm. Dis. 19, 146–148. 10.1097/00007435-199205000-00007
    1. Harmanli O. H., Cheng G. Y., Nyirjesy P., Chatwani A., Gaughan J. P. (2000). Urinary tract infections in women with bacterial vaginosis. Obstet. Gynecol. 95, 710–712. 10.1016/S0029-7844(99)00632-8
    1. Hashemi F. B., Ghassemi M., Faro S., Aroutcheva A., Spear G. T. (2000). Induction of human immunodeficiency virus type 1 expression by anaerobes associated with bacterial vaginosis. J. Infect. Dis. 181, 1574–1580. 10.1086/315455
    1. Hellberg D., Nilsson S., Mardh P. A. (2000). Bacterial vaginosis and smoking. Int. J. STD AIDS 11, 603–606. 10.1258/0956462001916461
    1. Hemmerling A., Harrison W., Schroeder A., Park J., Korn A., Shiboski S., et al. . (2009). Phase 1 dose-ranging safety trial of Lactobacillus crispatus CTV-05 for the prevention of bacterial vaginosis. Sex Transm. Dis. 36, 564–569. 10.1097/OLQ.0b013e3181a74924
    1. Hemmerling A., Harrison W., Schroeder A., Park J., Korn A., Shiboski S., et al. . (2010). Phase 2a study assessing colonization efficiency, safety, and acceptability of Lactobacillus crispatus CTV-05 in women with bacterial vaginosis. Sex Transm. Dis. 37, 745–750. 10.1097/OLQ.0b013e3181e50026
    1. Holst E., Brandberg A. (1990). Treatment of bacterial vaginosis in pregnancy with a lactate gel. Scand. J. Infect. Dis. 22, 625–626. 10.3109/00365549009027109
    1. Huang H., Song L., Zhao W. (2014). Effects of probiotics for the treatment of bacterial vaginosis in adult women: a meta-analysis of randomized clinical trials. Arch. Gynecol. Obstet. 289, 1225–1234. 10.1007/s00404-013-3117-0
    1. Human Microbiome Project Consortium (2012). Structure, function and diversity of the healthy human microbiome. Nature 486, 207–214. 10.1038/nature11234
    1. Hummelen R., Changalucha J., Butamanya N. L., Koyama T. E., Cook A., Habbema J. D., et al. . (2011). Effect of 25 weeks probiotic supplementation on immune function of HIV patients. Gut. Microbes. 2, 80–85. 10.4161/gmic.2.2.15787
    1. Hummelen R., Fernandes A. D., Macklaim J. M., Dickson R. J., Changalucha J., Gloor G. B., et al. . (2010). Deep sequencing of the vaginal microbiota of women with HIV. PLoS ONE 5:e12078. 10.1371/journal.pone.0012078
    1. Irvine S. L., Hummelen R., Hekmat S., Looman C. W., Habbema J. D., Reid G. (2010). Probiotic yogurt consumption is associated with an increase of CD4 count among people living with HIV/AIDS. J. Clin. Gastroenterol. 44, e201–e205. 10.1097/MCG.0b013e3181d8fba8
    1. Jakobsson T., Forsum U. (2007). Lactobacillus iners: a marker of changes in the vaginal flora? J. Clin. Microbiol. 45, 3145.
    1. Jespers V., Menten J., Smet H., Poradosu S., Abdellati S., Verhelst R., et al. . (2012). Quantification of bacterial species of the vaginal microbiome in different groups of women, using nucleic acid amplification tests. BMC Microbiol. 12:83. 10.1186/1471-2180-12-83
    1. Juarez Tomas M. S., Ocana V. S., Wiese B., Nader-Macias M. E. (2003). Growth and lactic acid production by vaginal Lactobacillus acidophilus CRL 1259, and inhibition of uropathogenic Escherichia coli. J. Med. Microbiol. 52, 1117–1124. 10.1099/jmm.0.05155-0
    1. Kaul R., Nagelkerke N. J., Kimani J., Ngugi E., Bwayo J. J., Macdonald K. S., et al. . (2007). Prevalent herpes simplex virus type 2 infection is associated with altered vaginal flora and an increased susceptibility to multiple sexually transmitted infections. J. Infect. Dis. 196, 1692–1697. 10.1086/522006
    1. Kaur B., Balgir P. P., Mittu B., Kumar B., Garg N. (2013). Biomedical applications of fermenticin HV6b isolated from Lactobacillus fermentum HV6b MTCC10770. Biomed. Res. Int. 168438. 10.1155/2013/168438
    1. Kilic A. O., Pavlova S. I., Alpay S., Kilic S. S., Tao L. (2001). Comparative study of vaginal Lactobacillus phages isolated from women in the United States and Turkey: prevalence, morphology, host range, and DNA homology. Clin. Diagn. Lab. Immunol. 8, 31–39. 10.1128/CDLI.8.1.31-39.2001
    1. Kiss H., Kogler B., Petricevic L., Sauerzapf I., Klayraung S., Domig K., et al. . (2007). Vaginal Lactobacillus microbiota of healthy women in the late first trimester of pregnancy. BJOG 114, 1402–1407. 10.1111/j.1471-0528.2007.01412.x
    1. Klebanoff M. A., Schwebke J. R., Zhang J., Nansel T. R., Yu K. F., Andrews W. W. (2004). Vulvovaginal symptoms in women with bacterial vaginosis. Obstet. Gynecol. 104, 267–272. 10.1097/01.AOG.0000134783.98382.b0
    1. Koumans E. H., Markowitz L. E., Hogan V. (2002). Indications for therapy and treatment recommendations for bacterial vaginosis in nonpregnant and pregnant women: a synthesis of data. Clin. Infect. Dis. 35(Suppl. 2), S152–S172. 10.1086/342103
    1. Lai S. K., Hida K., Shukair S., Wang Y. Y., Figueiredo A., Cone R., et al. . (2009). Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus. J. Virol. 83, 11196–11200. 10.1128/JVI.01899-08
    1. Lambert J. A., John S., Sobel J. D., Akins R. A. (2013). Longitudinal analysis of vaginal microbiome dynamics in women with recurrent bacterial vaginosis: recognition of the conversion process. PLoS ONE 8:e82599. 10.1371/journal.pone.0082599
    1. Larsson P. G., Stray-Pedersen B., Ryttig K. R., Larsen S. (2008). Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study. BMC Womens Health 8:3. 10.1186/1472-6874-8-3
    1. Lebeer S., Vanderleyden J., De Keersmaecker S. C. (2010). Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat. Rev. Microbiol. 8, 171–184. 10.1038/nrmicro2297
    1. Lee J. E., Lee S., Lee H., Song Y. M., Lee K., Han M. J., et al. . (2013). Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort. PLoS ONE 8:e63514. 10.1371/journal.pone.0063514
    1. Looker K. J., Garnett G. P., Schmid G. P. (2008). An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull. World Health Organ. 86, 805–812. 10.2471/BLT.07.046128
    1. Low N., Chersich M. F., Schmidlin K., Egger M., Francis S. C., van de Wijgert J. H., et al. . (2011). Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis. PLoS Med. 8:e1000416. 10.1371/journal.pmed.1000416
    1. Ma B., Brotman R. M., Gajer P., Fadrosh D., Mahurkar A., White O., et al. . (2013a). Association between chlamydia trachomatis genital infection and the vaginal microbiome. Sex Transm. Infect. 89:A35. 10.1136/sextrans-2013-051184.0110
    1. Ma L., Lv Z., Su J., Wang J., Yan D., Wei J., et al. . (2013b). Consistent condom use increases the colonization of Lactobacillus crispatus in the vagina. PLoS ONE 8:e70716. 10.1371/journal.pone.0070716
    1. Machado A., Jefferson K. K., Cerca N. (2013). Interactions between Lactobacillus crispatus and Bacterial Vaginosis (BV)-associated bacterial species in initial attachment and biofilm formation. Int. J. Mol. Sci. 14, 12004–12012. 10.3390/ijms140612004
    1. Macklaim J. M., Fernandes A. D., Di Bella J. M., Hammond J. A., Reid G., Gloor G. B. (2013). Comparative meta-RNA-seq of the vaginal microbiota and differential expression by Lactobacillus iners in health and dysbiosis. Microbiome 1:12. 10.1186/2049-2618-1-12
    1. Macklaim J. M., Gloor G. B., Anukam K. C., Cribby S., Reid G. (2011). At the crossroads of vaginal health and disease, the genome sequence of Lactobacillus iners AB-1. Proc. Natl. Acad. Sci. U.S.A. 108, 4688–4695. 10.1073/pnas.1000086107
    1. Malik S., Siezen R. J., Renckens B., Vaneechoutte M., Vanderleyden J., Lebeer S. (2014). Draft genome sequence of Lactobacillus plantarum CMPG5300, a human vaginal isolate. Genome Announc. 2, e01149–e01114. 10.1128/genomeA.01149-14
    1. Marcone V., Rocca G., Lichtner M., Calzolari E. (2010). Long-term vaginal administration of Lactobacillus rhamnosus as a complementary approach to management of bacterial vaginosis. Int. J. Gynaecol. Obstet. 110, 223–226. 10.1016/j.ijgo.2010.04.025
    1. Martin H. L., Richardson B. A., Nyange P. M., Lavreys L., Hillier S. L., Chohan B., et al. (1999). Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J. Infect. Dis. 180, 1863–1868.
    1. Martin D. H., Zozaya M., Lillis R., Miller J., Ferris M. J. (2012). The microbiota of the human genitourinary tract: trying to see the forest through the trees. Trans. Am. Clin. Climatol. Assoc. 123, 242–256.
    1. Martin R., Soberon N., Vaneechoutte M., Florez A. B., Vazquez F., Suarez J. E. (2008). Characterization of indigenous vaginal lactobacilli from healthy women as probiotic candidates. Int. Microbiol. 11, 261–266. 10.2436/20.1501.01.70
    1. Martin R., Suarez J. E. (2010). Biosynthesis and degradation of H2O2 by vaginal lactobacilli. Appl. Environ. Microbiol. 76, 400–405. 10.1128/AEM.01631-09
    1. Martinez R. C., Franceschini S. A., Patta M. C., Quintana S. M., Gomes B. C., De Martinis E. C., et al. . (2009). Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial. Can. J. Microbiol. 55, 133–138. 10.1139/W08-102
    1. Martinez R. C., Franceschini S. A., Patta M. C., Quintana S. M., Nunes A. C., Moreira J. L., et al. . (2008). Analysis of vaginal lactobacilli from healthy and infected Brazilian women. Appl. Environ. Microbiol. 74, 4539–4542. 10.1128/AEM.00284-08
    1. Martinez-Pena M. D., Castro-Escarpulli G., guilera-Arreola M. G. (2013). Lactobacillus species isolated from vaginal secretions of healthy and bacterial vaginosis-intermediate Mexican women: a prospective study. BMC Infect. Dis. 13:189. 10.1186/1471-2334-13-189
    1. Masese L., Baeten J. M., Richardson B. A., Bukusi E., John-Stewart G., Jaoko W., et al. . (2014). Incident herpes simplex virus type 2 infection increases the risk of subsequent episodes of bacterial vaginosis. J. Infect. Dis. 209, 1023–1027. 10.1093/infdis/jit634
    1. Massi M., Vitali B., Federici F., Matteuzzi D., Brigidi P. (2004). Identification method based on PCR combined with automated ribotyping for tracking probiotic Lactobacillus strains colonizing the human gut and vagina. J. Appl. Microbiol. 96, 777–786. 10.1111/j.1365-2672.2004.02228.x
    1. Mastromarino P., Brigidi P., Macchia S., Maggi L., Pirovano F., Trinchieri V., et al. . (2002). Characterization and selection of vaginal Lactobacillus strains for the preparation of vaginal tablets. J. Appl. Microbiol. 93, 884–893. 10.1046/j.1365-2672.2002.01759.x
    1. Mastromarino P., Cacciotti F., Masci A., Mosca L. (2011). Antiviral activity of Lactobacillus brevis towards herpes simplex virus type 2: role of cell wall associated components. Anaerobe 17, 334–336. 10.1016/j.anaerobe.2011.04.022
    1. Mastromarino P., Di P. M., Schiavoni G., Nardis C., Gentile M., Sessa R. (2014). Effects of vaginal lactobacilli in Chlamydia trachomatis infection. Int. J. Med. Microbiol. 304, 654–661. 10.1016/j.ijmm.2014.04.006
    1. Mastromarino P., Macchia S., Meggiorini L., Trinchieri V., Mosca L., Perluigi M., et al. . (2009). Effectiveness of Lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis. Clin. Microbiol Infect. 15, 67–74. 10.1111/j.1469-0691.2008.02112.x
    1. McMillan A., Macklaim J. M., Burton J. P., Reid G. (2013). Adhesion of Lactobacillus iners AB-1 to Human fibronectin: a key mediator for persistence in the vagina? Reprod. Sci. 20, 791–796. 10.1177/1933719112466306
    1. Mendes-Soares H., Suzuki H., Hickey R. J., Forney L. J. (2014). Comparative functional genomics of Lactobacillus spp. Reveals possible mechanisms for specialization of vaginal lactobacilli to their environment. J. Bacteriol. 196, 1458–1470. 10.1128/JB.01439-13
    1. Minton K. (2013). HIV: from one STI to another… with love. Nat. Rev. Immunol. 13, 154–155. 10.1038/nri3402
    1. Mitchell C., Balkus J. E., Fredricks D., Liu C., Kernan-Mullin J., Frenkel L. M., et al. . (2013). Interaction between lactobacilli, bacterial vaginosis-associated bacteria, and HIV Type 1 RNA and DNA genital shedding in U.S. and Kenyan women. AIDS Res. Hum. Retroviruses 29, 13–19. 10.1089/AID.2012.0187
    1. Nagot N., Ouedraogo A., Defer M. C., Vallo R., Mayaud P., Van de P. P. (2007). Association between bacterial vaginosis and Herpes simplex virus type-2 infection: implications for HIV acquisition studies. Sex Transm. Infect. 83, 365–368. 10.1136/sti.2007.024794
    1. Nardis C., Mosca L., Mastromarino P. (2013). Vaginal microbiota and viral sexually transmitted diseases. Ann. Ig. 25, 443–456. 10.7416/ai.2013
    1. Nugent R. P., Krohn M. A., Hillier S. L. (1991). Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J. Clin. Microbiol. 29, 297–301.
    1. Ogawa Y., Kawamura T., Matsuzawa T., Aoki R., Gee P., Yamashita A., et al. . (2013). Antimicrobial peptide LL-37 produced by HSV-2-infected keratinocytes enhances HIV infection of Langerhans cells. Cell Host. Microbe. 13, 77–86. 10.1016/j.chom.2012.12.002
    1. O'Hanlon D. E., Lanier B. R., Moench T. R., Cone R. A. (2010). Cervicovaginal fluid and semen block the microbicidal activity of hydrogen peroxide produced by vaginal lactobacilli. BMC Infect. Dis. 10:120. 10.1186/1471-2334-10-120
    1. O'Hanlon D. E., Moench T. R., Cone R. A. (2011). In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide. BMC Infect. Dis. 11:200. 10.1186/1471-2334-11-200
    1. Ojala T., Kankainen M., Castro J., Cerca N., Edelman S., Westerlund-Wikstrom B., et al. . (2014). Comparative genomics of Lactobacillus crispatus suggests novel mechanisms for the competitive exclusion of Gardnerella vaginalis. BMC Genomics 15:1070. 10.1186/1471-2164-15-1070
    1. Osset J., Bartolome R. M., Garcia E., Andreu A. (2001). Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells. J. Infect. Dis. 183, 485–491. 10.1086/318070
    1. Owusu-Edusei K., Jr., Chesson H. W., Gift T. L., Tao G., Mahajan R., Ocfemia M. C., et al. . (2013). The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008. Sex Transm. Dis. 40, 197–201. 10.1097/OLQ.0b013e318285c6d2
    1. Parent D., Bossens M., Bayot D., Kirkpatrick C., Graf F., Wilkinson F. E., et al. . (1996). Therapy of bacterial vaginosis using exogenously-applied Lactobacilli acidophili and a low dose of estriol: a placebo-controlled multicentric clinical trial. Arzneimittelforschung 46, 68–73.
    1. Pascual L. M., Daniele M. B., Giordano W., Pajaro M. C., Barberis I. L. (2008a). Purification and partial characterization of novel bacteriocin L23 produced by Lactobacillus fermentum L23. Curr. Microbiol. 56, 397–402. 10.1007/s00284-007-9094-4
    1. Pascual L. M., Daniele M. B., Ruiz F., Giordano W., Pajaro C., Barberis L. (2008b). Lactobacillus rhamnosus L60, a potential probiotic isolated from the human vagina. J. Gen. Appl. Microbiol. 54, 141–148. 10.2323/jgam.54.141
    1. Petricevic L., Domig K. J., Nierscher F. J., Sandhofer M. J., Fidesser M., Krondorfer I., et al. . (2014). Characterisation of the vaginal Lactobacillus microbiota associated with preterm delivery. Sci. Rep. 4:5136. 10.1038/srep05136
    1. Petricevic L., Witt A. (2008). The role of Lactobacillus casei rhamnosus Lcr35 in restoring the normal vaginal flora after antibiotic treatment of bacterial vaginosis. BJOG 115, 1369–1374. 10.1111/j.1471-0528.2008.01882.x
    1. Petrova M. I., van den B. M., Balzarini J., Vanderleyden J., Lebeer S. (2013). Vaginal microbiota and its role in HIV transmission and infection. FEMS Microbiol Rev. 37, 762–792. 10.1111/1574-6976.12029
    1. Phukan N., Parsamand T., Brooks A. E., Nguyen T. N., Simoes-Barbosa A. (2013). The adherence of Trichomonas vaginalis to host ectocervical cells is influenced by lactobacilli. Sex Transm. Infect. 89, 455–459. 10.1136/sextrans-2013-051039
    1. Rampersaud R., Planet P. J., Randis T. M., Kulkarni R., Aguilar J. L., Lehrer R. I., et al. . (2011). Inerolysin, a cholesterol-dependent cytolysin produced by Lactobacillus iners. J. Bacteriol. 193, 1034–1041. 10.1128/JB.00694-10
    1. Ravel J., Gajer P., Abdo Z., Schneider G. M., Koenig S. S., McCulle S. L., et al. . (2011). Vaginal microbiome of reproductive-age women. Proc. Natl. Acad. Sci. U.S.A. 1, 4680–4687. 10.1073/pnas.1002611107
    1. Reid G., Bruce A. W., Fraser N., Heinemann C., Owen J., Henning B. (2001). Oral probiotics can resolve urogenital infections. FEMS Immunol. Med. Microbiol. 30, 49–52. 10.1111/j.1574-695X.2001.tb01549.x
    1. Reid G., Cook R. L., Bruce A. W. (1987). Examination of strains of lactobacilli for properties that may influence bacterial interference in the urinary tract. J. Urol. 138, 330–335.
    1. Rizzo A., Losacco A., Carratelli C. R. (2013). Lactobacillus crispatus modulates epithelial cell defense against Candida albicans through Toll-like receptors 2 and 4, interleukin 8 and human beta-defensins 2 and 3. Immunol. Lett. 156, 102–109. 10.1016/j.imlet.2013.08.013
    1. Ross S. A., Novak Z., Ashrith G., Rivera L. B., Britt W. J., Hedges S., et al. . (2005). Association between genital tract cytomegalovirus infection and bacterial vaginosis. J. Infect. Dis. 192, 1727–1730. 10.1086/497150
    1. Rose W. A., McGowin C. L., Spagnuolo R. A., Eaves-Pyles T. D., Popov V. L., Pyles R. B. (2012). Commensal bacteria modulate innate immune responses of vaginal epithelial cell multilayer cultures. PLoS ONE 7:e32728. 10.1371/journal.pone.0032728
    1. Santiago G. L., Cools P., Verstraelen H., Trog M., Missine G., El A. N., et al. . (2011). Longitudinal study of the dynamics of vaginal microflora during two consecutive menstrual cycles. PLoS ONE 6:e28180. 10.1371/journal.pone.0028180
    1. Santiago G. L., Tency I., Verstraelen H., Verhelst R., Trog M., Temmerman M., et al. . (2012). Longitudinal qPCR study of the dynamics of L. crispatus, L. iners, A. vaginae, (sialidase positive) G. vaginalis, and P. bivia in the vagina. PLoS ONE 7:e45281. 10.1371/journal.pone.0045281
    1. Schwebke J. R., Desmond R. (2007). A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent the acquisition of sexually transmitted diseases. Am. J. Obstet. Gynecol. 196, 517–516. 10.1016/j.ajog.2007.02.048
    1. Senok A. C., Verstraelen H., Temmerman M., Botta G. A. (2009). Probiotics for the treatment of bacterial vaginosis. Cochrane. Database. Syst. Rev. 4:CD006289. 10.1002/14651858.CD006289.pub2
    1. Sha B. E., Zariffard M. R., Wang Q. J., Chen H. Y., Bremer J., Cohen M. H., et al. . (2005). Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. J. Infect. Dis. 191, 25–32. 10.1086/426394
    1. Shi Y., Chen L., Tong J., Xu C. (2009). Preliminary characterization of vaginal microbiota in healthy Chinese women using cultivation-independent methods. J. Obstet. Gynaecol. Res. 35, 525–532. 10.1111/j.1447-0756.2008.00971.x
    1. Shipitsyna E., Roos A., Datcu R., Hallen A., Fredlund H., Jensen J. S., et al. . (2013). Composition of the vaginal microbiota in women of reproductive age–sensitive and specific molecular diagnosis of bacterial vaginosis is possible? PLoS ONE 8:e60670. 10.1371/journal.pone.0060670
    1. Shukair S. A., Allen S. A., Cianci G. C., Stieh D. J., Anderson M. R., Baig S. M., et al. . (2013). Human cervicovaginal mucus contains an activity that hinders HIV-1 movement. Mucosal. Immunol. 6, 427–434. 10.1038/mi.2012.87
    1. Siezen R. J., Kleerebezem M. (2011). The human gut microbiome: are we our enterotypes? Microb. Biotechnol. 4, 550–553. 10.1111/j.1751-7915.2011.00290.x
    1. Smith B. C., McAndrew T., Chen Z., Harari A., Barris D. M., Viswanathan S., et al. . (2012). The cervical microbiome over 7 years and a comparison of methodologies for its characterization. PLoS ONE 7:e40425. 10.1371/journal.pone.0040425
    1. Spear G. T., Gilbert D., Landay A. L., Zariffard R., French A. L., Patel P., et al. . (2011). Pyrosequencing of the genital microbiotas of HIV-seropositive and -seronegative women reveals Lactobacillus iners as the predominant Lactobacillus Species. Appl. Environ. Microbiol. 77, 378–381. 10.1128/AEM.00973-10
    1. Spear G. T., Sikaroodi M., Zariffard M. R., Landay A. L., French A. L., Gillevet P. M. (2008). Comparison of the diversity of the vaginal microbiota in HIV-infected and HIV-uninfected women with or without bacterial vaginosis. J. Infect. Dis. 198, 1131–1140. 10.1086/591942
    1. Spurbeck R. R., Arvidson C. G. (2008). Inhibition of Neisseria gonorrhoeae epithelial cell interactions by vaginal Lactobacillus species. Infect. Immun. 76, 3124–3130. 10.1128/IAI.00101-08
    1. Spurbeck R. R., Arvidson C. G. (2010). Lactobacillus jensenii surface-associated proteins inhibit Neisseria gonorrhoeae adherence to epithelial cells. Infect. Immun. 78, 3103–3111. 10.1128/IAI.01200-09
    1. Srinivasan S., Hoffman N. G., Morgan M. T., Matsen F. A., Fiedler T. L., Hall R. W., et al. . (2012). Bacterial communities in women with bacterial vaginosis: high resolution phylogenetic analyses reveal relationships of microbiota to clinical criteria. PLoS ONE 7:e37818. 10.1371/journal.pone.0037818
    1. Srinivasan S., Liu C., Mitchell C. M., Fiedler T. L., Thomas K. K., Agnew K. J., et al. . (2010). Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. PLoS ONE 5:e10197. 10.1371/journal.pone.0010197
    1. Strus M., Brzychczy-Wloch M., Gosiewski T., Kochan P., Heczko P. B. (2006). The in vitro effect of hydrogen peroxide on vaginal microbial communities. FEMS Immunol. Med. Microbiol. 48, 56–63. 10.1111/j.1574-695X.2006.00120.x
    1. Swidsinski A., Doerffel Y., Loening-Baucke V., Swidsinski S., Verstraelen H., Vaneechoutte M., et al. . (2010). Gardnerella biofilm involves females and males and is transmitted sexually. Gynecol. Obstet. Invest. 70, 256–263. 10.1159/000314015
    1. Tamrakar R., Yamada T., Furuta I., Cho K., Morikawa M., Yamada H., et al. . (2007). Association between Lactobacillus species and bacterial vaginosis-related bacteria, and bacterial vaginosis scores in pregnant Japanese women. BMC Infect. Dis. 7:128. 10.1186/1471-2334-7-128
    1. Tanton C., Weiss H. A., Le G. J., Changalucha J., Rusizoka M., Baisley K., et al. . (2011). Correlates of HIV-1 genital shedding in Tanzanian women. PLoS ONE 6:e17480. 10.1371/journal.pone.0017480
    1. van de Wijgert J. H., Borgdorff H., Verhelst R., Crucitti T., Francis S., Verstraelen H., et al. (2014). The vaginal microbiota: what have we learned after a decade of molecular characterization? PLoS ONE 9:e105998.
    1. van de Wijgert J. H., Morrison C. S., Brown J., Kwok C., Van der P. B., Chipato T., et al. . (2009). Disentangling contributions of reproductive tract infections to HIV acquisition in African Women. Sex Transm. Dis. 36, 357–364. 10.1097/OLQ.0b013e3181a4f695
    1. Vasquez A., Jakobsson T., Ahrne S., Forsum U., Molin G. (2002). Vaginal lactobacillus flora of healthy Swedish women. J. Clin. Microbiol. 40, 2746–2749. 10.1128/JCM.40.8.2746-2749.2002
    1. Velraeds M. M., van de Belt-Gritter B., van der Mei H. C., Reid G., Busscher H. J. (1998). Interference in initial adhesion of uropathogenic bacteria and yeasts to silicone rubber by a Lactobacillus acidophilus biosurfactant. J. Med. Microbiol. 47, 1081–1085.
    1. Verhelst R., Verstraelen H., Claeys G., Verschraegen G., Delanghe J., Van S. L., et al. . (2004). Cloning of 16S rRNA genes amplified from normal and disturbed vaginal microflora suggests a strong association between Atopobium vaginae, Gardnerella vaginalis and bacterial vaginosis. BMC Microbiol. 4:16. 10.1186/1471-2180-4-16
    1. Verhelst R., Verstraelen H., Claeys G., Verschraegen G., Van S. L., De G. C., et al. . (2005). Comparison between Gram stain and culture for the characterization of vaginal microflora: definition of a distinct grade that resembles grade I microflora and revised categorization of grade I microflora. BMC Microbiol. 5:61. 10.1186/1471-2180-5-61
    1. Verhoeven V., Renard N., Makar A., Van R. P., Bogers J. P., Lardon F., et al. . (2013). Probiotics enhance the clearance of human papillomavirus-related cervical lesions: a prospective controlled pilot study. Eur. J. Cancer Prev. 22, 46–51. 10.1097/CEJ.0b013e328355ed23
    1. Verstraelen H., Delanghe J., Roelens K., Blot S., Claeys G., Temmerman M. (2005). Subclinical iron deficiency is a strong predictor of bacterial vaginosis in early pregnancy. BMC Infect. Dis. 5:55. 10.1186/1471-2334-5-55
    1. Verstraelen H., Swidsinski A. (2013). The biofilm in bacterial vaginosis: implications for epidemiology, diagnosis and treatment. Curr. Opin. Infect. Dis. 26, 86–89. 10.1097/QCO.0b013e32835c20cd
    1. Verstraelen H., Verhelst R., Claeys G., Temmerman M., Vaneechoutte M. (2004). Culture-independent analysis of vaginal microflora: the unrecognized association of Atopobium vaginae with bacterial vaginosis. Am. J. Obstet. Gynecol. 191, 1130–1132. 10.1016/j.ajog.2004.04.013
    1. Vicariotto F., Del P. M., Mogna L., Mogna G. (2012). Effectiveness of the association of 2 probiotic strains formulated in a slow release vaginal product, in women affected by vulvovaginal candidiasis: a pilot study. J. Clin. Gastroenterol. 10.1097/MCG.0b013e3182684d71
    1. Vielfort K., Sjolinder H., Roos S., Jonsson H., Aro H. (2008). Adherence of clinically isolated lactobacilli to human cervical cells in competition with Neisseria gonorrhoeae. Microbes. Infect. 10, 1325–1334. 10.1016/j.micinf.2008.07.032
    1. Wagner R. D., Johnson S. J. (2012). Probiotic lactobacillus and estrogen effects on vaginal epithelial gene expression responses to Candida albicans. J. Biomed. Sci. 19:58. 10.1186/1423-0127-19-58
    1. Watts D. H., Fazzari M., Minkoff H., Hillier S. L., Sha B., Glesby M., et al. . (2005). Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women. J. Infect. Dis. 191, 1129–1139. 10.1086/427777
    1. Wiesenfeld H. C., Hillier S. L., Krohn M. A., Landers D. V., Sweet R. L. (2003). Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin. Infect. Dis. 36, 663–668. 10.1086/367658
    1. Witkin S. S., Mendes-Soares H., Linhares I. M., Jayaram A., Ledger W. J., Forney L. J. (2013). Influence of vaginal bacteria and D- and L-lactic acid isomers on vaginal extracellular matrix metalloproteinase inducer: implications for protection against upper genital tract infections. MBio 4, e00460–e00413. 10.1128/mBio.00460-13
    1. Ya W., Reifer C., Miller L. E. (2010). Efficacy of vaginal probiotic capsules for recurrent bacterial vaginosis: a double-blind, randomized, placebo-controlled study. Am. J. Obstet. Gynecol. 203, 120–126. 10.1016/j.ajog.2010.05.023
    1. Zarate G., Nader-Macias M. E. (2006). Influence of probiotic vaginal lactobacilli on in vitro adhesion of urogenital pathogens to vaginal epithelial cells. Lett. Appl. Microbiol. 43, 174–180. 10.1111/j.1472-765X.2006.01934.x
    1. Zhou X., Bent S. J., Schneider M. G., Davis C. C., Islam M. R., Forney L. J. (2004). Characterization of vaginal microbial communities in adult healthy women using cultivation-independent methods. Microbiology 150, 2565–2573. 10.1099/mic.0.26905-0
    1. Zhou X., Hansmann M. A., Davis C. C., Suzuki H., Brown C. J., Schutte U., et al. (2010). The vaginal bacterial communities of Japanese women resemble those of women in other racial groups. FEMS Immunol. Med. Microbiol. 58, 169–181 10.1111/j.1574-695X.2009.00618.x
    1. Zhu J., Hladik F., Woodward A., Klock A., Peng T., Johnston C., et al. . (2009). Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat. Med. 15, 886–892. 10.1038/nm.2006

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner